Design, Synthesis, and Anticancer Evaluation of Pyrimidine-based Derivatives
Oriental Journal Of Chemistry · 01.03.2026 · 1 (42) · 328
DOI: 10.13005/ojc/420135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 28.02.2026. Verfasst von Raj Kumari und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer remains a leading global health challenge, driving an urgent need for novel therapeutic agents that offer greater efficacy and safety. The pyrimidine nucleus, a foundational component of DNA, RNA, and key cofactors, stands as a privileged scaffold in anticancer drug discovery. This systematic review comprehensively analyzes the design, synthesis, and biological evaluation of new pyrimidine-based derivatives reported over the past decade. We detail modern design strategies, including molecular hybridization with heterocycles and natural products, scaffold morphing via ring fusion, and rational targeting of critical pathways such as kinase signaling (EGFR, VEGFR, CDKs) and nucleotide metabolism (TS, DHFR). The synthesis of these libraries leverages both classical cyclocondensation reactions and advanced, efficient methodologies. A critical analysis of in vitro data across diverse cancer cell lineages reveals potent, often nanomolar, cytotoxicity and elucidates established mechanisms of action, including apoptosis induction, cell cycle arrest, and enzyme inhibition. A comprehensive Structure-Activity Relationship (SAR) discussion identifies key pharmacophoric features and substituent effects governing potency and selectivity. Despite promising results, significant challenges remain, particularly the frequent lack of in vivo validation and detailed mechanistic studies. Future progress hinges on integrating computational chemistry for rational design and ADMET prediction, exploring emerging targets, and rigorously pursuing the translational pathway to clinically viable, multi-targeted anticancer agents.
Zitieren
APA
Kumari, R., Burakle, P. V., Salma, A., Kapoor, B., Kulkarni, M. H., Badadhe, S. G., Varshney, H., Kumar, M., & Raghuwanshi, M. (2026). Design, Synthesis, and Anticancer Evaluation of Pyrimidine-based Derivatives. Oriental Journal Of Chemistry, 1(42), 328. https://doi.org/10.13005/ojc/420135
Vancouver
Kumari R, Burakle PV, Salma A, Kapoor B, Kulkarni MH, Badadhe SG, et al. Design, Synthesis, and Anticancer Evaluation of Pyrimidine-based Derivatives. Oriental Journal Of Chemistry. 2026;1(42):328. doi:10.13005/ojc/420135
BibTeX
@article{Kumari2026,
author = {Kumari, Raj and Burakle, Pramod V and Salma, Afrin and Kapoor, Bhawana and Kulkarni, Mrunalini Harish and Badadhe, Sandip Gahininath and Varshney, Himank and Kumar, Mohit and Raghuwanshi, Mona},
title = {Design, Synthesis, and Anticancer Evaluation of Pyrimidine-based Derivatives},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {1},
number = {42},
pages = {328},
doi = {10.13005/ojc/420135}
}
EUVIMED